BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuhlmann KF, van Till JW, Boermeester MA, de Reuver PR, Tzvetanova ID, Offerhaus GJ, Ten Kate FJ, Busch OR, van Gulik TM, Gouma DJ, Crawford HC. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2007;16:886-91. [PMID: 17507610 DOI: 10.1158/1055-9965.EPI-06-0779] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu H, Guo JC, Yang SH, Tien YW, Kuo SH. Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer. J Clin Med 2019;8:E1115. [PMID: 31357636 DOI: 10.3390/jcm8081115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287-5297. [PMID: 19738110 DOI: 10.1200/JCO.2009.] [Reference Citation Analysis]
3 Firpo MA, Gay DZ, Granger SR, Scaife CL, DiSario JA, Boucher KM, Mulvihill SJ. Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen. World J Surg 2009;33:716-22. [PMID: 19082654 DOI: 10.1007/s00268-008-9853-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
4 Jaboin JJ, Hwang M, Lopater Z, Chen H, Ray GL, Perez C, Cai Q, Wills ML, Lu B. The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2011;79:1330-5. [PMID: 20605361 DOI: 10.1016/j.ijrobp.2010.01.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jiang C, Wang J, Dong C, Wei W, Li J, Li X. Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis. Oncol Lett 2017;14:3096-102. [PMID: 28927056 DOI: 10.3892/ol.2017.6536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
6 Mohan V, Gaffney JP, Solomonov I, Levin M, Klepfish M, Akbareian S, Grünwald B, Dym O, Eisenstein M, Yu KH, Kelsen DP, Krüger A, Edwards DR, Sagi I. Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill. Cancers (Basel) 2021;13:1679. [PMID: 33918254 DOI: 10.3390/cancers13071679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bhat K, Wang F, Ma Q, Li Q, Mallik S, Hsieh TC, Wu E. Advances in biomarker research for pancreatic cancer. Curr Pharm Des 2012;18:2439-51. [PMID: 22372502 DOI: 10.2174/13816128112092439] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
8 Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X. Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. Onco Targets Ther. 2017;10:4591-4598. [PMID: 28979147 DOI: 10.2147/ott.s145708] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
9 Granger JH, Granger MC, Firpo MA, Mulvihill SJ, Porter MD. Toward development of a surface-enhanced Raman scattering (SERS)-based cancer diagnostic immunoassay panel. Analyst 2013;138:410-6. [PMID: 23150876 DOI: 10.1039/c2an36128k] [Cited by in Crossref: 61] [Cited by in F6Publishing: 9] [Article Influence: 8.7] [Reference Citation Analysis]
10 Lertudomphonwanit C, Mourya R, Fei L, Zhang Y, Gutta S, Yang L, Bove KE, Shivakumar P, Bezerra JA. Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia. Sci Transl Med 2017;9:eaan8462. [PMID: 29167395 DOI: 10.1126/scitranslmed.aan8462] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 13.3] [Reference Citation Analysis]
11 Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, Brentnall TA. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010;39:981-988. [PMID: 20467349 DOI: 10.1097/mpa.0b013e3181dac920] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
12 Tan AC, Jimeno A, Lin SH, Wheelhouse J, Chan F, Solomon A, Rajeshkumar NV, Rubio-Viqueira B, Hidalgo M. Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol 2009;3:425-38. [PMID: 19497796 DOI: 10.1016/j.molonc.2009.03.004] [Cited by in Crossref: 98] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
13 Yang M, Zhang C, Zhang MZ, Zhang S. Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria. BMC Microbiol 2018;18:54. [PMID: 29871599 DOI: 10.1186/s12866-018-1190-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
14 Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015;21:4323-33. [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
15 Reindel R, Baker SC, Kim KY, Rowley CA, Shulman ST, Orenstein JM, Perlman EJ, Lingen MW, Rowley AH. Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy. Pediatr Res 2013;73:332-6. [PMID: 23344661 DOI: 10.1038/pr.2012.185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
16 Isaacson KJ, Martin Jensen M, Subrahmanyam NB, Ghandehari H. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. J Control Release 2017;259:62-75. [PMID: 28153760 DOI: 10.1016/j.jconrel.2017.01.034] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
17 Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics 2011;10:M111.008599. [PMID: 21653254 DOI: 10.1074/mcp.M111.008599] [Cited by in Crossref: 78] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
18 Nukarinen E, Lindström O, Kuuliala K, Kylänpää L, Pettilä V, Puolakkainen P, Kuuliala A, Hämäläinen M, Moilanen E, Repo H, Hästbacka J. Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study. PLoS One 2016;11:e0161480. [PMID: 27561093 DOI: 10.1371/journal.pone.0161480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
19 Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287-5297. [PMID: 19738110 DOI: 10.1200/jco.2009.23.5556] [Cited by in Crossref: 533] [Cited by in F6Publishing: 249] [Article Influence: 44.4] [Reference Citation Analysis]
20 Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg 2013;257:17-26. [PMID: 22895395 DOI: 10.1097/SLA.0b013e31825ffbfb] [Cited by in Crossref: 120] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
21 Dalbec KM, Max Schmidt C, Wade TE, Wang S, Swartz-Basile DA, Pitt HA, Zyromski NJ. Adipokines and cytokines in human pancreatic juice: unraveling the local pancreatic inflammatory milieu. Dig Dis Sci 2010;55:2108-12. [PMID: 19757043 DOI: 10.1007/s10620-009-0977-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Slapak EJ, Duitman J, Tekin C, Bijlsma MF, Spek CA. Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? Biology (Basel) 2020;9:E80. [PMID: 32325664 DOI: 10.3390/biology9040080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
23 Worthley DL, Giraud AS, Wang TC. The extracellular matrix in digestive cancer. Cancer Microenviron 2010;3:177-85. [PMID: 21209783 DOI: 10.1007/s12307-010-0053-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
24 Gopalan V, Singh A, Rashidi Mehrabadi F, Wang L, Ruppin E, Arda HE, Hannenhalli S. A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC. Cancer Res 2021;81:3958-70. [PMID: 34049974 DOI: 10.1158/0008-5472.CAN-21-0427] [Reference Citation Analysis]